Koji Izumi
(泉 浩司)
Modified on: 01/17
Profile Information
- Degree
-
博士(医学)(横浜市立大学)
- J-GLOBAL ID
- 201701002548621864
- researchmap Member ID
- 7000019384
- External link
アンドロゲンレセプター(AR)シグナルが膀胱癌の発生、進展に関与していることが明らかになってきている。我々は後ろ向き研究で前立腺癌に対する抗アンドロゲン療法が膀胱癌の再発率を有意に低くする事を報告した。現在膀胱癌におけるARシグナルの作用メカニズムの解明を進めると同時に、臨床的に抗アンドロゲン療法の膀胱癌再発抑制効果を見るための前向き試験を検討している。
Research Interests
3Research Areas
3Research History
1Papers
35-
Scandinavian journal of urology, 1-7, Mar, 2017 Peer-reviewed
-
BMC CANCER, 16(1) 944, Dec, 2016 Peer-reviewed
-
CLINICAL GENITOURINARY CANCER, 14(4) E291-E297, Aug, 2016 Peer-reviewed
-
BMC Cancer, 16(1) 396, Jul 7, 2016 Peer-reviewed
-
BMC urology, 16(1) 32-32, Jun 17, 2016 Peer-reviewed
-
BMC cancer, 16 185-185, Mar 5, 2016 Peer-reviewed
-
ONCOTARGET, 7(12) 14153-14160, Mar, 2016 Peer-reviewed
-
Oncotarget, 6(31) 32169-76, Oct 13, 2015 Peer-reviewed
-
WORLD JOURNAL OF UROLOGY, 33(10) 1519-1526, Oct, 2015 Peer-reviewed
-
CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 9(1-2) E30-E32, Jan, 2015 Peer-reviewed
-
AMERICAN JOURNAL OF CANCER RESEARCH, 5(2) 738-747, 2015 Peer-reviewed
-
ONCOTARGET, 5(24) 12665-12674, Dec, 2014 Peer-reviewed
-
MOLECULAR CARCINOGENESIS, 53(4) 314-324, Apr, 2014 Peer-reviewed
-
CANCER BIOLOGY & THERAPY, 15(4) 428-435, Apr, 2014 Peer-reviewed
-
AMERICAN JOURNAL OF CANCER RESEARCH, 4(5) 461-473, 2014 Peer-reviewed
-
HUMAN PATHOLOGY, 44(8) 1556-1562, Aug, 2013 Peer-reviewed
-
ENDOCRINE-RELATED CANCER, 20(3) 293-304, Jun, 2013 Peer-reviewed
-
MOLECULAR CARCINOGENESIS, 52(2) 94-102, Feb, 2013 Peer-reviewed
-
MOLECULAR CANCER THERAPEUTICS, 11(12) 2621-2632, Dec, 2012 Peer-reviewed
-
HUMAN PATHOLOGY, 43(11) 2033-2040, Nov, 2012 Peer-reviewed